Published in J Neurol Neurosurg Psychiatry on June 01, 1982
Cerebral edema with irreversible coma in severe diabetic ketoacidosis. N Engl J Med (1967) 2.34
The specific binding of L-tryptophan to serum albumin. J Biol Chem (1958) 2.20
Unbound amino acid concentrations in human blood plasmas. J Clin Invest (1957) 1.95
Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem (1972) 1.53
Fatal Diabetic Ketosis. Br Med J (1961) 1.46
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Physiologic aspects of ketosis. Metabolism (1956) 1.18
Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry (1970) 1.11
Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science (1978) 1.11
Pathogenesis and therapy of hepatic coma. Prog Liver Dis (1976) 1.07
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Alteration of plasma albumin in relation to decreased drug binding in uremia. Clin Pharmacol Ther (1977) 0.96
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
Binding of indole analogues to human serum albumin. Effects of fatty acids. J Biol Chem (1965) 0.94
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem (1976) 0.93
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
Reduced in vitro binding of tryptophan by plasma in uremia. Kidney Int (1974) 0.89
A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma. Anal Biochem (1977) 0.89
Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan. J Neurochem (1981) 0.86
Drugs altering insulin secretion: effects on plasma and brain concentrations of aromatic amino acids and on brain 5-hydroxytryptamine turnover. Br J Pharmacol (1977) 0.86
Cerebral transmitter precursors and metabolites in advanced renal disease. J Neurol Neurosurg Psychiatry (1978) 0.85
Increased tryptophan hydroxylase activity may compensate for decreased brain tryptophan levels in streptozotocin-diabetic rats. J Pharmacol Exp Ther (1980) 0.83
Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci I (1970) 0.82
Acute changes in brain tryptophan and serotonin after carbohydrate or protein ingestion by diabetic rats. Diabetes (1980) 0.79
Hyperlipidemia with ketoacidosis. Metabolism (1962) 0.78
Brain monoamines in metabolic coma and stroke. Adv Neurol (1978) 0.77
Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease. J Neurol Neurosurg Psychiatry (1980) 0.77
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
The production of superoxide anion radicals in the reaction of reduced flavins and flavoproteins with molecular oxygen. Biochem Biophys Res Commun (1969) 2.72
Parasexual genetic analysis of Candida albicans by spheroplast fusion. J Bacteriol (1981) 2.65
Restless legs syndrome in uremic neuropathy. Neurology (1966) 2.52
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Recombination analysis of naturally diploid Candida albicans. J Bacteriol (1982) 2.20
Germ tube induction in Candida albicans. Can J Microbiol (1980) 2.04
Candida albicans: biology, genetics, and pathogenicity. Annu Rev Microbiol (1985) 2.04
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J Infect Dis (1990) 1.80
The reactivity of flavoproteins with sulfite. Possible relevance to the problem of oxygen reactivity. J Biol Chem (1969) 1.75
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J Gen Microbiol (1990) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry (1985) 1.51
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
An analysis of the metabolism and cell wall composition of Candida albicans during germ-tube formation. Can J Microbiol (1983) 1.41
Management of migraine. Ir Med J (1992) 1.38
Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol (1982) 1.36
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. J Neurol Neurosurg Psychiatry (1978) 1.34
A second gene for a secreted aspartate proteinase in Candida albicans. J Bacteriol (1992) 1.32
Plasma prolactin concentrations following epileptic and pseudoseizures. J Neurol Neurosurg Psychiatry (1983) 1.30
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Regulation of chitin synthesis during germ-tube formation in Candida albicans. Arch Microbiol (1980) 1.29
Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun (1996) 1.29
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
The production and growth characteristics of yeast and mycelial forms of Candida albicans in continuous culture. J Gen Microbiol (1976) 1.26
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol (1975) 1.23
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
Analysis of wall glucans from yeast, hyphal and germ-tube forming cells of Candida albicans. J Gen Microbiol (1984) 1.22
Aspiration: cause and implications. Otolaryngol Head Neck Surg (1999) 1.22
Candida acid proteinases. J Med Vet Mycol (1992) 1.21
Mechanism of action of the flavoenzyme lactate oxidase. J Biol Chem (1972) 1.20
The alternate respiratory pathway of Candida albicans. Arch Microbiol (1978) 1.19
What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension (1984) 1.19
The migraine syndrome in pregnancy. Neurology (1968) 1.16
Kinetics of beta-1,3 glucan interaction at the donor and acceptor sites of the fungal glucosyltransferase encoded by the BGL2 gene. Eur J Biochem (1995) 1.15
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation (1990) 1.14
Dialysis dementia: recovery after transplantation. Br Med J (1977) 1.12
Coeliac disease and epilepsy. QJM (1998) 1.12
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
Chemical modification of cellulase from Aspergillus niger. Biochem J (1977) 1.09
The structure of the exo-beta-(1,3)-glucanase from Candida albicans in native and bound forms: relationship between a pocket and groove in family 5 glycosyl hydrolases. J Mol Biol (1999) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Phenobarbitone in previously untreated epilepsy. J Neurol Neurosurg Psychiatry (1980) 1.03
Purification and properties of a cellulase from Aspergillus niger. Biochem J (1977) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
The inhibition of ornithine transcarbamoylase from Escherichia coli W by phaseolotoxin. Biochem J (1984) 1.02
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Analysis of secreted aspartic proteinases from Candida albicans: purification and characterization of individual Sap1, Sap2 and Sap3 isoenzymes. Microbiology (1997) 1.00
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
Exo-(1----3)-beta-glucanase, autolysin and trehalase activities during yeast growth and germ-tube formation in Candida albicans. J Gen Microbiol (1984) 1.00
Isolation and structure of glucan from regenerating spheroplasts of Candida albicans. J Gen Microbiol (1984) 0.99
The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure (1995) 0.99
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
How should dysphagia care of older adults differ? Establishing optimal practice patterns. Semin Speech Lang (2000) 0.99
A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med (1986) 0.98
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
Characterization of a tetraploid derivative of Candida albicans ATCC 10261. J Bacteriol (1985) 0.97
The in situ assay of Candida albicans enzymes during yeast growth and germ-tube formation. J Gen Microbiol (1983) 0.96
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
N-acetyl-D-glucosamine-induced morphogenesis in Candida albicans. Microbiologica (1985) 0.95
Landre-Guillain-Barre syndrome associated with recent herpes virus hominis infection. Ir Med J (1974) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95
The secretion of N-acetylglucosaminidase during germ-tube formation in Candida albicans. J Gen Microbiol (1984) 0.94
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
Inhibitors of caeruloplasmin. Biochem J (1967) 0.94
An exo-beta-(1,3)-glucanase of Candida albicans: purification of the enzyme and molecular cloning of the gene. J Gen Microbiol (1993) 0.94
Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J (1974) 0.94